UROVANT SCIENCES GMBH has a total of 32 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Taiwan. Its main competitors in its focus markets pharmaceuticals are CONTERA PHARMA APS, SZABO GYOERGY and HANGZHOU SHARPLY PHARMACEUTICAL RES & DEV INST CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 5 | |
#3 | Taiwan | 4 | |
#4 | Australia | 3 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | United States | 2 | |
#10 | Brazil | 1 | |
#11 | Chile | 1 | |
#12 | Philippines | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Piscitelli Stephen C | 16 |
#2 | Mudd Paul | 16 |
#3 | Haag-Molkenteller Cornelia | 9 |
#4 | Zhou Jihao | 9 |
#5 | Schaumburg Chris | 6 |
#6 | Mudd Jr | 6 |
#7 | Nicandro Jean Paul Abrian | 6 |
#8 | Melman Arnold | 3 |
#9 | Mudd Paul N | 2 |
#10 | Mudd Jr Paul N | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020188505A1 | Use of vibegron to treat overactive bladder | |
TW202038963A | Use of vibegron to treat overactive bladder symptoms in men with benign prostatic hyperplasia | |
TW202039531A | Compositions and methods for the treatment of smooth muscle dysfunction | |
AU2019273837A1 | Use of vibegron to treat pain associated with irritable bowel syndrome | |
AU2018282104A1 | Use of vibegron to treat overactive bladder | |
CN110869053A | Administration of vebairon to treat overactive bladder |